Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANYSNAKES antivenom study for snakebite management
PACTR202605894319801Phase 3Not yet recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Sep 2026
- Modality
- Fab Fragments → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 2
01
Overview
Phase 3 trial of EchiTAb Plus ICP, EchiTAb G and Antivipmyn, sponsored by Liverpool School of Tropical Medicine. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
EchiTAb Plus ICPEchiTAb GAntivipmyn
Beyond the preview
Go deeper on PACTR202605894319801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605894319801.